CASEY JOHNSTON: Open Payments
NPI 1952684631 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,618 in 77 payments from 15 companies in 2025. Trend: 2023 $34 · 2024 $1,309 · 2025 $1,618
Food & beverage: $1,409Education: $209
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $382 |
| Novartis Pharmaceuticals Corporation | 20 | $321 |
| Janssen Biotech, Inc. | 6 | $239 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $191 |
| Biofrontera Inc. | 4 | $85 |
| Arcutis Biotherapeutics, Inc. | 4 | $75 |
| UCB, Inc. | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 3 | $59 |
| Galderma Laboratories, L.P. | 2 | $41 |
| PFIZER INC. | 2 | $36 |
Products named: COSENTYX, SKYRIZI, TREMFYA, ILUMYA, RINVOQ, Zoryve, Bimzelx, LIBTAYO.
Industry payments across UT — which companies pay providers there.
